Information on Pros and Cons of Prostate-Specific Antigen Testing to Men Prior to Blood Draw: A Study From the National Prostate Cancer Register (NPCR) of Sweden

Scandinavian Journal of Urology and Nephrology
doi 10.3109/00365599.2012.691110
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Capture Rate and Representativity of the National Prostate Cancer Register of Sweden

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2014English

Prostate-Specific Antigen Velocity in a Prospective Prostate Cancer Screening Study of Men With Genetic Predisposition

British Journal of Cancer
Cancer ResearchOncology
2018English

Prospective Observational Study to Assess Value of Prostate Specific Antigen as Screening Test for Prostate Cancer

BMJ
1995English

Plasma Carotenoids and Tocopherols in Relation to Prostate-Specific Antigen (PSA) Levels Among Men With Biochemical Recurrence of Prostate Cancer

Cancer Epidemiology
Cancer ResearchEpidemiologyOncology
2015English

Prevalence of Prostate Cancer Among Men With a Prostate-Specific Antigen Level ≤4.0 Ng Per Milliliter

New England Journal of Medicine
Medicine
2004English

The Role of Prostate-Specific Antigen in Prostate Cancer Screening

Romanian Review of Laboratory Medicine
2014English

Discoveries and Application of Prostate-Specific Antigen, and Some Proposals to Optimize Prostate Cancer Screening

Cancer Management and Research
Oncology
2016English

Comparison Between Circulating Immune Complexes and Prostate Specific Antigen to Assess the Pathogenesis of Prostate Cancer

Journal of Cancer Treatment and Research
2017English

Prostate-Specific Membrane Antigen From Diagnostic to Therapeutic Target: Radionuclide Therapy Comes of Age in Prostate Cancer

BJU International
Urology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy